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Deep brain stimulation (DBS) is an effective surgical treatment for drug-resistant 
neurological movement disorders like Parkinson’s disease and essential tremor. However, 
as the complexity of DBS leads increases, the standard method for stimulation parameter 
titration will become increasingly challenging and definitive parameter search more time-
consuming. For this reason, we proposed a connectivity-based approach using patient-
specific cortical connectivity for predicting clinical outcome, and designed our study to 
serve as a proof-of-concept for automating stimulation parameter titration. Specifically, we 
obtained brain images from a cohort of 24 Parkinson’s patients implanted with 
subthalamic nucleus (STN) DBS and calculated the differences in connectivity to cortical 
regions in the whole brain associated with specific clinical observations sorted by clinical 
outcome: “Improvement” or “Side Effect.” We then reduced the number of cortical regions 
using reverse sequential feature selection before training a linear support vector machine 
(SVM) using 10-fold cross validation to classify clinical observations by clinical outcome 
using their associated differences in cortical connectivity. This SVM was then used to 
predict the most efficacious contact for each DBS lead, as well as the most efficacious 
voltage at each contact on each lead. The SVM achieved an overall classification error of 
10.99%, and predicted the most efficacious contact with an average absolute deviation of 
0.89, 1.17 and 1.08 contacts and 0.77, 1.10 and 1.21 V from the initial, 1 year and final 
stimulation parameter settings respectively. Additionally, it was found that 44.1% of the 
contacts were non-efficacious with 6 leads being entirely non-efficacious. Though these 
results are relatively modest, together they suggest that our metric is informative for 
predicting clinical outcome and narrowing down stimulation parameters. In the future, we 
hope to refine our algorithm to improve performance considerably. Our study serves as a 









Deep Brain Stimulation 
Deep brain stimulation (DBS) is an effective surgical treatment method for drug-resistant 
neurological movement disorders, though its potential is also being explored for various 
other neurological and psychological disorders (Miocinovic et al. 2013). Specifically, DBS is 
currently an FDA-approved therapy for essential tremor and Parkinson’s disease, and has a 
humanitarian device exemption for dystonia and obsessive-compulsive disorder (OCD) 
(Miocinovic et al. 2013). However, despite the great success DBS has shown in treating 
these disorders, its exact therapeutic mechanisms are unclear. 
 
The DBS system typically consists of one lead for each cerebral hemisphere with 4 
stimulating contacts each, which can be placed either unilaterally (ie: in a single 
hemisphere) or bilaterally (ie: in both hemispheres) (Miocinovic et al. 2013). Each of the 
contacts can be stimulated individually (unipolar stimulation) or in combination 
(multipolar stimulation) (Miocinovic et al. 2013). By testing multiple stimulation 
parameters, the most effective set of parameters can be found by balancing therapeutic 







Figure 1: Each DBS lead is inserted through an opening in the skill deep into the brain tissue terminating in a 
target site, such as the subthalamic nucleus (STN). Patients can be implanted either unilaterally (one lead, 
single hemisphere) or bilaterally (two leads, both hemispheres) (“Deep Brain Stimulation for Parkinson’s 
Disease” 2018). The lead(s) are then powered by a wire routed to a portable neurostimulator under the skin 
in the chest area (“Deep Brain Stimulation for Parkinson’s Disease” 2018). 
 
Deep Brain Stimulation for Parkinson’s Disease 
Parkinson’s disease is a progressive neurodegenerative disorder that manifests primarily 
as bradykinesia (a slowing of movements), rigidity (stiffness) and tremors (uncontrolled 
shaking of the limbs) due to a depletion of dopamine (Kalia and Lang 2015). Though 
dopaminergic treatments like levodopa are effective in reducing these symptoms, patients 
may develop side effects (ie: dyskinesia) or fluctuations in the clinical efficacy. DBS is an 
adjunct to medical treatment for advanced Parkinson’s patients with excellent long-term 
clinical efficacy (Schuepbach et al. 2013). The most common targeting sites include the 
subthalamic nucleus (STN) and globus pallidus internus (GPi) (Williams, Foote, and Okun 
2014). Because Parkinson’s DBS is one of the most commonly performed DBS procedures, 
we applied our algorithm first to this disorder, though it is could arbitrarily be extended to 




Stimulation Parameter Titration 
Once the DBS leads have been implanted in the target regions, the next step is to test 
different stimulation parameters in what is known as programming or stimulation 
parameter titration. The specific parameters that can be optimized include the optimal 
electrode contact(s), stimulation voltage(s), pulse width and frequency, and can be 
visualized via their corresponding volume of tissue activation(s) (VTA) (Miocinovic et al. 
2013). An illustration of the VTA resulting from stimulation is shown in Figure 2: 
 
 
Figure 2: The volume of tissue activation (VTA) can be modeled by simulating the interaction between the 
electrical field generated by the lead and the surrounding tissue (Buhlmann et al. 2011). Stimulation can be 
done either in a monopolar (single contact, left) or multipolar fashion (multiple contacts, right) in order to 
stimulate different areas of the surrounding tissue (Buhlmann et al. 2011). 
 
Traditionally, stimulation parameter titration has been done through a systematic, trial-
and-error process in which each contact is tested independently with varying sets of 
parameters, while noting clinical improvements and side effects (Picillo et al. 2016a, 
2016b). This process most typically takes anywhere from 30 to 120 minutes per DBS lead 
(Ondo, Bronte-Stewart, and DBS Study Group 2005). Though the final stimulation 
parameters are selected by the end of the initial programming session, these parameters 
may require adjustment over successive clinical visits (Miocinovic et al. 2013). However, 
this method for stimulation parameter selection will become more challenging, and 
definitive parameter search more time-consuming, as more complex lead setups with 
higher contact counts and directional stimulation capabilities become more common 
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(Schüpbach et al. 2017; Anderson et al. 2018). For this reason, automated methods for 
stimulation titration incorporating brain connectivity are needed. 
 
Tractography for Deep Brain Stimulation 
Though the exact therapeutic mechanisms of DBS are still unclear, the leading hypothesis is 
that the electrical stimulation of neural elements, neuronal cell bodies and axons, 
surrounding the DBS lead has local and downstream network-level effects resulting in 
clinical efficacy (Okun and Oyama 2013). These network-level effects are likely mediated 
primarily through the white matter tracts projecting from and surrounding the target site, 
which is in alignment with previous in vitro studies (Okun and Oyama 2013; Nowak and 
Bullier 1998). These white matter tracts can be studied in vivo using diffusion tensor 
imaging (DTI), by modeling the diffusion properties of water molecules in the brain (Assaf 
and Pasternak 2008). Tractography is the computational reconstruction method which 
utilizes the diffusion information from DTI to infer the trajectories of these white matter 
pathways and thus the underlying structural connectivity in the brain (Maier-Hein et al. 
2017). Because clinical observations commonly appear after incremental changes in 
stimulation parameters, by modeling the differences in stimulation volume, it may be 
feasible to study the changes in structural connectivity associated with these stimulation-
induced clinical observations using tractography. We hypothesize that the additional 
cortical connectivity associated with stimulation adjustment may be involved in the 
appearance of stimulation-induced clinical effect. 
 
Support Vector Machines 
The support vector machine (SVM) is a common machine learning method that has been 
applied successfully to a variety of classification problems (Salcedo-Sanz et al. 2014). 
Mathematically, the SVM is defined as maximum margin classifier, the goal of which is to 
identify the hyperplane(s) within the high dimensional feature space that maximally 
segregates the class(es) (Salcedo-Sanz et al. 2014). These hyperplanes then serve as the 
decision boundaries by which the trained SVM classifies an observation as one class or 
another (Salcedo-Sanz et al. 2014). Because of its definition, the output of an SVM will 
always correspond to the mathematically optimal decision boundaries for the given 
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training data (Salcedo-Sanz et al. 2014). The SVM therefore is a reasonable method by 
which to consistently determine whether specific features are predictive of a classification. 
An illustration of the principle by which SVMs classify data is shown in Figure 3: 
 
 
Figure 3: Illustration of linear SVM Classification. The purpose of the SVM is to find the optimal decision 
boundary in feature space between classes, while maximizing the margin of separation and minimizing 
misclassification error. Though illustration shows this principle in 3-dimensional space, this can be arbitrarily 
extended to higher dimensional feature spaces as well (which cannot as easily be visualized). 
 
OBJECTIVE 
In its current state, stimulation parameter titration is a systematic, trial-and-error method, 
which can be rather time-consuming for both the patient and clinician. Though this 
traditional method has been highly successful, it may become more challenging and time-
consuming as the complexity of DBS lead setups increases. For this reason, we propose a 
connectivity-based approach using patient-specific cortical connectivity to predict specific 
stimulation settings with a high likelihood for good outcome. Additionally, we aim to use 
this study as a proof-of-concept for a connectivity-based approach for automated 








In this study, we retrospectively examined a cohort of 24 Parkinson’s patients implanted 
with STN DBS at the Center for Neuromodulation in the Ohio State Wexner Medical Center. 
All patients signed informed consent, and the study was approved by the Ohio State 
University Wexner Medical Center Ethics Board. Preoperatively, all patients underwent 
both T1 (1mm isovoxel, MPRAGE) and diffusion-weighted imaging (DTI, 64 directions, 
2mm isovoxel, whole-brain acquisition) on a Philips Ingenia CX 3 Tesla magnet, using a 
padded 32 channel bird cage coil to minimize discomfort and head motion. Postoperatively, 
all patients underwent a CT scan of the head 4-6 weeks after implantation of DBS 
electrodes. T1-weighted MR images were used for visualizing patient-specific anatomy. DTI 
images were used for estimating whole-brain diffusivity. CT images were used to localize 
the final location of the implanted DBS leads using the electrode artifacts. Together, these 
images formed the basis of our stimulation modeling and whole-brain connectivity 
analysis. Examples of each image acquisition are shown in the figures following: 
 
 
Figure 4: Diffusion tensor image (DTI) displayed as a raw T1-weighted MR image (left), along with 
corresponding fractional anisotropy (FA) maps in greyscale (middle) and color (right) (Tromp 2009). 
Fractional anisotropy is a method which quantifies the relative length of each diffusion tensor in comparison 
to its width, or analogously quantifies the fraction of the tensor that is non-isotropic (Tromp 2009). This 
provides a measure of the direction of diffusivity of water molecules in the brain, which move preferentially 





Figure 5: The metallic contacts of the DBS lead can be seen in the postoperative CT images by their electrode 
artifacts (Zhang 2013). These artifacts can be used to localize the final location of the contacts for use in later 
stimulation modeling. 
 
Stimulation Parameter Titration 
During stimulation parameter titration, the voltage was varied for each individual contact 
in a step-wise manner while maintaining a frequency of 130 Hz and pulse width of 90 µs. 
Though one of the cases did include bipolar stimulation, the majority of the cases were 
monopolar. This resulted in 355 unique voltage changes in 38 leads (14 bilateral, 2 right, 8 
left) across the entire 24-patient cohort. For each voltage change, clinical effects were 
noted and classified into “Improvement” or “Side Effect” (119 and 236 voltage changes 
respectively) in 15 clinical domains. These domains were as follows: rigidity (domain 1), 
bradykinesia (domain 2), tremor (domain 3) improvement; and sensory (domain 4), motor 
(domain 5), limbic (domain 6), dyskinesia (domain 7), eye deviations (domain 8), gait 
(domain 9), dizziness (10), other (11), dystonia (12), sweating (domain 13), fatigue 
(domain 14) and vision changes (domain 15) side effect. 
 
Image Processing 
Images were preprocessed using our custom, MATLAB-based DBSProcessor pipeline, that 
interfaced with standard neuroimaging software packages such as FSL and Lead-DBS 
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(“MATLAB - MathWorks” 2018; Jenkinson et al. 2012; Horn and Kühn 2015). The CT, DTI 
and T1-weighted MR images of 24 patients were first deidentified then imported and 
converted from DICOM to NIfTI format for analysis. The DTI images were pre-processed for 
motion artifact correction (eddy_correct, FSL suite), and run through DTIFIT (DTIFIT, FSL 
suite) to estimate the diffusion tensors and BEDPOSTX (bedpostx, FSL suite) for Bayesian 
estimation of the diffusion parameters at each voxel. Then, the CT and T1-weighted MR 
images were co-registered and normalized to a high-resolution, 0.5mm MNI-ICBM 152 
group brain template from the ICBM 2009b Nonlinear Asymmetric atlas using Lead-DBS's 
ANTs implementation (Fonov et al. 2009). The leads were then localized (and visually 
confirmed) and each unique VTA pair associated with the voltage changes calculated using 
Lead-DBS. A nonlinear transform was then calculated from diffusion to ICBM-MNI template 
space (FNIRT, FSL suite). 
 
To estimate patient-specific connectivity, whole-brain probabilistic tractography using 
PROBTRACKX (probtrackx2, FSL suite) was then performed between each voxel in each 
patient's native diffusion space. The settings included the omatrix2 option, 100 samples per 
voxel, a curvature threshold of 0.2, a maximum number of steps per sample of 2000, a step 
length of 0.5 mm, a subsidiary fiber volume threshold of 0.01 and a loopback check. The 
connectivity matrix generated by probabilistic tractography was then used to infer the 
strength of connectivity from each VTA to 360 distinct cortical regions segmented by 
hemisphere. The change in connectivity between each VTA pair was then statistically 
thresholded  to isolate significant connectivity changes from baseline (Glasser et al. 2016). 
The resulting “differential” cortical connectivity feature vectors were then used in further 
analysis. 
 
Stimulation Parameter Prediction 
After generating the connectivity data, we then trained a linear SVM (fitcsvm, MATLAB 
toolbox) to classify the changes in cortical connectivity corresponding to particular clinical 
voltage changes by clinical outcome as “Improvement” or “Side Effect.” In order to ensure a 
parsimonious model, the 360 cortical regions used previously were narrowed down to only 
the most predictive regions using reverse sequential feature selection. This optimal set of 
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features was then used in final training. Finally, 10-fold cross validation with 250 10-fold 
iterations was used to ensure the generalizability of our model, with the overall error on 
the entire dataset serving as the final performance metric for our linear SVM classifier. 
Next, the most efficacious contacts for each lead was predicted using the SVM predictions, 
by determining the highest efficacious voltage predicted before encountering side effects. 
The center of mass of the contacts was then computed for each prediction, and compared 
to that of the initial, 1 year and final stimulation parameter settings. Similarly, the 
predicted voltage was likewise compared to the that of the initial, 1 year and final 
stimulation parameter settings. The averages of the absolute deviations were then taken to 




The final result of reverse sequential feature selection was 156 cortical regions that were 


















Hemisphere Cortical Regions 
Right V6, V4, 4, 3b, PEF, RSC, POS2, V7, IPS1, V3B, LO2, 
PIT, PSL, 7Pm, 23d, v23ab, d23ab, 5m, 5L, 24dv, 
6ma, 7Am, VIP, 2, 6d, 6v, a24pr, a24, 10r, 8Ad, 10d, 
45, a47r, IFJa, IFJp, IFSp, 11l, 13l, 47s, LIPd, 43, OP4, 
PFcm, PoI2, TA2, FOP4, FOP3, H, ProS, STGa, PBelt, 
STSdp, STSvp, TGd, TE1a, TE2a, TF, PH, TPOJ2, IP1, 
IP0, PF, PFm, V6A, VMV1, VMV3, PHA2, V4t, V3CD, 
VMV2, 31pd, 31a, VVC, FOP5, MBelt, LBelt, A4, 
STSva 
Left 55b, 5mv, p24pr, 8BM, 8Av, 9p, 44, IFSa, 10v, OP1, 
RI, AAIC, AIP, PFop, PGs, LO3, PoI1, p24 
Both MIP, p32, 8C, 6r, a9-46v, 9-46d, a10p, i6-8, OP2-3, 
MI, FOP1, EC, PreS, A5, PHA1, TE1p, TPOJ1, TPOJ3, 
DVT, PGp, IP2, PGi, FST, 25, pOFC, Ig, p10p, TGv, 
TE1m, a32pr 
Table 1: Most predictive cortical regions as sorted by hemisphere. 
 
These regions were then translated into their corresponding cortical areas, then sorted by 
their primary cortical functions. The sorted cortical areas are listed in Table 2: 
 
Primary Function Cortical Areas 
Motor PFC, Broca’s Area, PMC, SMA, M1, POS 
Sensory 5M, 24’, MIP, S1, 5, 5L 
Visual FEF, AIP, DVT, PG, FST, LO, V3, V4, V6,  V7, PEF, IPS, 
PIT, 7, 7A, VIP, PH, VMV, VVC 
Limbic Insular Cortex, Subgenual Area, OFC, TG, 25 
Other 55b, 32, 32’, 8A, IFS, OP, Entorhinal Cortex, 
Presubiculum, A1, A4, A5, PHA1, TPOJ, 24, RSC, PSL, 
23, 47, IFJ, 11, 13, 43, 40, Hippocampus, 
Prosubiculum, STG, STS, TF 







A linear SVM was trained (fitcsvm, MATLAB toolbox) to classify VTA changes using their 
corresponding “differential” cortical connectivity feature vectors to the aforementioned 
156 cortical regions using 10-fold cross validation (“MATLAB - MathWorks” 2018). The 
best performing SVM model was then used to predict clinical outcome for all 355 VTA 
changes. This resulted in an overall classification error of 10.99%. 
 
The SVM was then used to classify the most efficacious contacts based on the contacts that 
displayed the highest voltage associated with improvement before encountering any side 
effects. This prediction was then compared to the initial, one year and final stimulation 
parameter settings. The predictions were found to deviate on average from the 
experimentally-chosen contacts and voltages by 0.89, 1.17 and 1.08 contacts and 0.77, 1.10 
and 1.21 V respectively. Additionally, it was found that 44.1% (67 out of 152) of the 
contacts predicted were non-efficacious (ie: 0 V prediction) with 6 leads being entirely 











Figure 6: The highest efficacious voltage predicted at for each contact in each hemisphere for all 24 patients 
was predicted. This was then used to determine the most efficacious contact. Note that in some cases, no 
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Table 3: The prediction for the most efficacious contact and voltage for each hemisphere in each patient 
versus the final contact chosen after the initial, 1 year and final sessions is shown above. (“RH” = Right 




Justification of the Approach 
In designing our approach, we first considered utilizing the location of stimulation to 
predict patient outcome. However, in a previous study by Nestor et al. (2014), it was found 
that the position and trajectory of the DBS lead relative to the mid-comissural point (MCP) 
alone was unable to reliable predict motor improvement. This finding is likely due to the 
fact that this approach fails to adequately accounts for the great neuroanatomical 
variability exhibited across patients (Nestor et al. 2014). Thus, it is also unlikely that 
anatomical location alone would be sufficient to predict the varied clinical outcomes 
observed during stimulation parameter titration. For this reason, we turned to a 





Analysis of the literature informed the potential validity of using a connectivity-based 
approach. Traditionally, there have been two competing explanations to improve the 
clinical efficacy of STN-DBS: 1) that stimulation deactivates neurons creating a sort of 
functional lesion and 2) that stimulation activates STN output neurons to “jam” errant 
activity in the basal ganglia-thalamocortical circuits (Carlson et al. 2010). However, in a 
study by Carlson et al. (2010), it was shown that DBS shifted firing in STN neurons towards 
more randomized patterns of activity, suggesting a modulation of brain networks in 
accordance with the latter hypothesis. Further research suggests that DBS modulates 
coupling between the STN and multiple, spatially-distinct areas of the cortex (Silberstein et 
al. 2005; Oswal et al. 2016). This has also been backed by more recent tractography-based 
studies, in which it has been found that DBS targets preferentially project to many of the 
same proposed network components (Koirala et al. 2016; Riva-Posse et al. 2018). However, 
the accuracy of tractography in determining local connectivity is potentially limited due to 
ambiguity introduced by fiber crossing (Maier-Hein et al. 2017). Finally, research also 
suggests that the networks modulated by DBS may be distinct to specific clinical domains, 
such as tremor, and may even be bilateral in nature (Timmermann et al. 2003; de Solages et 
al. 2010). 
 
The previous research suggests that utilizing cortical connectivity to predict clinical 
outcome is a reasonable approach, as well as that it could be useful to segment the chosen 
cortical targets by hemisphere. In fact, the validity of a functional connectivity-based 
approach for modeling stimulation-induced network modulation and to predict 
neurostimulation strengths and targets has already been shown (Chen et al. 2017). 
Likewise, it has been shown that structural connectivity, using both whole-brain 
connectome and constrained tractography-based approaches, can be used to predict motor 
improvement (Horn and Kühn 2015; Akram et al. 2017). These studies suggest that the 
therapeutic effect of DBS is mediated through the modulated by a variety of regions within 
distinct motor networks. However, no study has to our knowledge aimed to study whole-
brain structural connectivity using patient-specific tractography or utilized the 
connectivity associated with non-motor side effects. For this reason, we decided to take an 
unbiased approach, in which we would initially include connectivity to all regions. 
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However, because of the potential ambiguity of local connectivity, we chose to forgo the 
inclusion of the more local subcortical regions in this study, instead including only the 
more distal cortical regions derived from a cortical atlas. We then used reverse sequential 




Though the number of narrowed-down, predictive features shown in Table 1 was relatively 
large, it was found upon sorting in Table 2 that the majority of the areas made up by these 
regions were associated with specific neurological functions, including motor (domains 1, 
2, 3, 5, and 7), sensory (domain 4), visual (domains 8 and 15) or limbic (domain 6). This 
suggests that the accurate prediction of clinical outcome in Parkinson’s requires 
information from a relatively large number of widely-distributed regions. This finding can 
be explained by the variety of clinical domains used in this study, which included both 
motor and non-motor effects, as well as the aforementioned findings that DBS modulates 
spatially-distributed networks in the brain (Silberstein et al. 2005; Oswal et al. 2016). 
However, further research is necessary to identify the relative importance of these regions 
in predicting clinical outcome, as well as their contribution to the prediction of individual 
clinical domains. By doing so, it would be possible to not only better understand the 
importance of these cortical regions in Parkinsonian dysfunction, but also to better tune 
the machine learning approach. 
 
Prediction Results 
While the overall classification error of 10.99% is relatively modest, it suggests that cortical 
connectivity changes are informationally useful for predicting the clinical outcome 
associated with specific DBS stimulation parameters. This is backed by the finding that 
these predictions can be used to predict the most efficacious contact with an average 
absolute deviation of 0.89, 1.17 and 1.08 contacts and 0.77, 1.10 and 1.21 V from the initial, 
1 year and final stimulation parameter settings respectively. Though performance in 
contact and voltage prediction remains relatively stable, it does appear to decrease slightly 
over time. This may be due to the inclusion of only acute observations during stimulation 
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parameter titration, and, if so, it is likely that including observations from later sessions 
would increase performance of the algorithm in predicting contacts chronically. 
Additionally, it was found that 44.1% of the contacts predicted were non-efficacious with 6 
leads being entirely non-efficacious. This suggests our algorithm could be used to eliminate 
a large number of contacts from stimulation parameter titration. However, as can be seen 
in Table 3, working settings were nonetheless found on the 6 entirely non-efficacious leads. 
This phenomenon may partially be explained by atypical connectivity patterns from these 
leads or non-ideal targeting locations, but requires further investigation. Together, these 
findings suggest the potential feasibility of personalized DBS parameter predictions 
tailored to individual patients, using patient-specific cortical connectivity derived from 
diffusion-weighted brain imaging.  
 
In order to improve prediction performance, it is likely that further research will be 
necessary in both feature selection and machine learning approach. The number of cortical 
features is still rather large, and so it would be fruitful to investigate alternative feature 
selection methods to the one used in this study. Additionally, it is likely that the 
incorporation and/or substitution of alternative connectivity metrics, derived from 
alternative tractography techniques, subcortical connectivity, or even functional 
connectivity, could improve performance and minimize the number of features. Further, 
though the linear SVM approach used in this study was useful as a first-pass method to 
assess the utility of using our patient-specific cortical connectivity metric to predict clinical 
outcome, it is likely that more complex kernel-based methods or neural networks will be 
able to better to parse out the complex trends in cortical connectivity and with less features 
(Hofmann, Schölkopf, and Smola 2008; LeCun, Bengio, and Hinton 2015). 
 
Finally, though our algorithm currently only predicts overall clinical outcome, it could be 
extended to the prediction of clinical outcome in specific clinical domains. By doing this, it 
will be possible not only to predict whether or not a given stimulation parameter 
combination will be efficacious, but also in what areas specifically the stimulation will lead 
to improvement or side effect. This could then be used in tandem with a relative weighting 
scheme, perhaps based on the number and types of improvement or side effect and their 
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severity or the strength of the voltage needed, to more robustly predict the voltage that will 
be most efficacious at each contact and to rank these contacts using a weighted efficacy 
score. These could then serve as starting points for stimulation parameter titration, greatly 
reducing the extent of parameter search. 
 
CONCLUSION 
This study is a useful first step towards the automation of stimulation parameter titration 
for DBS surgery. Specifically, we’ve proposed a patient-specific cortical connectivity metric 
using structural connectivity, as estimated by probabilistic tractography, from the site of 
stimulation to predict clinical outcome using a linear SVM. Our SVM achieved an overall 
classification error of 10.99% and average absolute contact and voltage deviation 0.89, 
1.17 and 1.08 contacts and 0.77, 1.10 and 1.21 V from the initial, 1 year and final 
stimulation parameter settings respectively. Additionally, 44.1% of the contacts were 
found to be non-efficacious with 6 leads being entirely non-efficacious. Though these 
results are relatively modest, together they suggest that our metric is informative for 
predicting clinical outcome and narrowing down stimulation parameters. By refining our 
algorithm using more complex feature selection and machine learning methods and 
supplementing it with chronic observations and alternative connectivity metrics, we hope 
to improve performance considerably. Additionally, we hope to adapt our algorithm to 
predict the clinical domain(s) of the clinical outcome. By doing so, we will better be able to 
determine the maximally effective voltage at each contact, which can be used as a starting 
point for stimulation parameter titration. Ultimately, this will help to narrow down the 
parameter search space, saving time for both the patient and clinician and paving the way 
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